Pharmaceutical Patent Settlements: How the Turducken is Made
11 AM EST
"Reverse payment" patent settlement cases have been called a “turducken,” referring to the complexity of litigating a patent case inside an antitrust case. Following the Supreme Court’s Actavis decision, we have seen the turducken peeled back and examined repeatedly. But how does a pharmaceutical patent settlement come to be, and how are companies managing their antitrust risk in the post-Actavis environment? This panel will offer a unique look at these questions by taking the audience through the process of patent litigation, settlement considerations, antitrust review, and, ultimately, FTC review, with the help of experts who are involved every step of the way.